publication venue for
- Examination of Health System Resources and Costs Associated With Transitioning Cancer Survivors to Primary Care: A Propensity-Score-Matched Cohort Study. 14:682-+. 2018
- Examination of Health System Resources and Costs Associated With Transitioning Cancer Survivors to Primary Care: A Propensity-Score–Matched Cohort Study. 14:e653-e664. 2018
- Curative Stereotactic Ablative Radiotherapy for a Locally Advanced Basal Cell Carcinoma in an Elderly Patient. 14:389-391. 2018
- Case for Stopping Targeted Therapy When Lung Cancer Progresses on Treatment in Hospice-Eligible Patients. 13:780-783. 2017
- Has Province-Wide Symptom Screening Changed Opioid Prescribing Rates in Older Patients With Cancer?. 13:e927-e934. 2017
- American Society of Clinical Oncology Policy Brief: FDA’s Regulation of Electronic Nicotine Delivery Systems and Tobacco Products. 13:58-60. 2017
- Positron Emission Tomography–Computed Tomography (PET-CT) Versus No PET-CT in the Management of Potentially Resectable Colorectal Cancer Liver Metastases: Cost Implications of a Randomized Controlled Trial. 12:e765-e774. 2016
- Perspective on the National Comprehensive Cancer Network’s (NCCN) Clinical Practice Guidelines for Smoking Cessation. 12:55-58. 2016
- Quality Indicators of End-of-Life Care in Patients With Cancer: What Rate Is Right?. 11:e279-e287. 2015
- Supporting Models to Transition Breast Cancer Survivors to Primary Care: Formative Evaluation of a Cancer Care Ontario Initiative. 11:e288-e295. 2015
- Challenges Faced by Pediatric Oncology Fellows When Patients Die During Their Training. 11:e182-e189. 2015
- Creation of a Diagnostic Wait Times Measurement Framework Based on Evidence and Consensus. 10:e373-e379. 2014
- Cost-Effectiveness Analysis Comparing Conventional Versus Stereotactic Body Radiotherapy for Surgically Ineligible Stage I Non–Small-Cell Lung Cancer. 10:e130-e136. 2014
- Cost Effectiveness of a Survivorship Care Plan for Breast Cancer Survivors. 10:e86-e92. 2014
- Oncologists' Strategies and Barriers to Effective Communication About the End of Life. 9:e129-e135. 2013
- Use of Continuous Infusion Pumps During Radiation Treatment. 9:107-111. 2013
- Do High Symptom Scores Trigger Clinical Actions? An Audit After Implementing Electronic Symptom Screening. 8:e142-e148. 2012
- Technology Resource Planning in Radiation Oncology: Application of a Needs-Based Analytic Framework to Radiosurgery Planning in Ontario. 8:358-362. 2012
- Multidisciplinary Health Care Professionals' Perceptions of the Use and Utility of a Symptom Assessment System for Oncology Patients. 7:19-23. 2011
- American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update on the Use of Epoetin and Darbepoetin in Adult Patients With Cancer. 6:317-320. 2010
- Who Is Responsible? The Role of Family Physicians in the Provision of Supportive Cancer Care. 6:19-24. 2010
- American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction. 5:196-199. 2009
- Cancer Care Ontario and American Society of Clinical Oncology Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Stages I-IIIA Resectable Non–Small-Cell Lung Cancer Guideline. 3:332-335. 2007